ArticleFrontiers in oncology2026

Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis.

Shrila Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.